Ribociclib in advanced breast cancer: Survival advantages, but also severe side effects
(Institute for Quality and Efficiency in Health Care) Study indicates longer overall survival of postmenopausal women. However, there is a higher frequency of severe diseases of blood and lymphatic system. Overall, added benefit not proven.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Health Management | International Medicine & Public Health | Study | Women